Results
|
|
3321.
|
Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. [electronic resource] by
- Rajah, S M
- Nair, U
- Rees, M
- Saunders, N
- Walker, D
- Williams, G
- Critchley, A
- Beton, D
- Campbell, C
- Lawson, R A
Producer: 19940516
In:
The Journal of thoracic and cardiovascular surgery vol. 107
Availability: No items available.
|
|
|
3322.
|
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. [electronic resource] by
- Davi, G
- Alessandrini, P
- Mezzetti, A
- Minotti, G
- Bucciarelli, T
- Costantini, F
- Cipollone, F
- Bon, G B
- Ciabattoni, G
- Patrono, C
Producer: 19980122
In:
Arteriosclerosis, thrombosis, and vascular biology vol. 17
Availability: No items available.
|
|
|
3323.
|
|
|
|
3324.
|
|
|
|
3325.
|
|
|
|
3326.
|
|
|
|
3327.
|
|
|
|
3328.
|
|
|
|
3329.
|
|
|
|
3330.
|
|
|
|
3331.
|
|
|
|
3332.
|
Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits. [electronic resource] by
- Smith, Susan M E
- Min, Jaeki
- Ganesh, Thota
- Diebold, Becky
- Kawahara, Tsukasa
- Zhu, Yerun
- McCoy, James
- Sun, Aiming
- Snyder, James P
- Fu, Haian
- Du, Yuhong
- Lewis, Iestyn
- Lambeth, J David
Producer: 20140303
In:
Chemistry & biology vol. 19
Availability: No items available.
|
|
|
3333.
|
|
|
|
3334.
|
|
|
|
3335.
|
Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model. [electronic resource] by
- Lorito, Guiscardo
- Hatzopoulos, Stavros
- Laurell, Göran
- Campbell, Kathleen C M
- Petruccelli, Joseph
- Giordano, Pietro
- Kochanek, Krzysztof
- Sliwa, Lech
- Martini, Alessandro
- Skarzynski, Henryk
Producer: 20111121
In:
Medical science monitor : international medical journal of experimental and clinical research vol. 17
Availability: No items available.
|
|
|
3336.
|
|
|
|
3337.
|
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors. [electronic resource] by
- Do, Khanh
- Speranza, Giovanna
- Chang, Lun-Ching
- Polley, Eric C
- Bishop, Rachel
- Zhu, Weimin
- Trepel, Jane B
- Lee, Sunmin
- Lee, Min-Jung
- Kinders, Robert J
- Phillips, Larry
- Collins, Jerry
- Lyons, John
- Jeong, Woondong
- Antony, Ramya
- Chen, Alice P
- Neckers, Len
- Doroshow, James H
- Kummar, Shivaani
Producer: 20160512
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
|
3338.
|
|
|
|
3339.
|
|
|
|
3340.
|
|